Gerald Pier, of Harvard Medical School in Boston, and his colleagues, think they have the answer: typhoid fever.

ECONOMIST: Cystic fibrosis and typhoid fever: A Faustian bargain | The

The drug giant convened the ten-member panel, headed by Eugene Braunwald of Harvard Medical School in Boston, to examine the safety of heart-failure treatment Natrecor.

FORBES: Magazine Article

Dr. Green is a medical geneticist at Brigham and Women's Hospital and Harvard Medical School in Boston and associate director for research at the Partners Center for Personalized Genetic Medicine.

WSJ: Should Healthy People Have Their Genomes Sequenced?

Hartzband and Groopman are on the faculty of the Harvard Medical School and the Beth Israel Deaconess Medical Center in Boston.

WSJ: Hartzband and Groopman on the Rise of the Medical Expertocracy

Professor David Sinclair also works in Boston at an ageing laboratory at Harvard Medical School.

BBC: Stop, rewind: the scientists slowing the ageing process

Szostak was previously at Harvard Medical School and is currently professor of genetics at Massachusetts General Hospital in Boston, Massachusetts.

CNN: 3 Americans win medicine Nobel for chromosome research

"We were delighted to find that patients who get the current state-of-the-art treatment with platelet blockers, medical treatment and stents during procedures had a significant improvement in their outcome, " said Dr. Christopher Cannon, an assistant professor at Harvard Medical School and a principal investigator for a number of heart-related studies at Brigham and Women's Hospital in Boston, Massachusetts.

CNN: Research closing in on heart disease